- US-listed companies
- Dolby Laboratories, Inc.
Dolby Laboratories, Inc.DLB
Market cap
$8B
P/E ratio
42.2x
Sep 24, 2010 | Sep 28, 2012 | Sep 27, 2013 | Sep 26, 2014 | Sep 25, 2015 | Sep 30, 2016 | Sep 29, 2017 | Sep 28, 2018 | Sep 27, 2019 | Sep 25, 2020 | Sep 24, 2021 | Sep 30, 2022 | Sep 29, 2023 | |
Revenue | 923 | 926 | 910 | 960 | 971 | 1,026 | 1,081 | 1,172 | 1,242 | 1,162 | 1,281 | 1,254 | 1,300 |
Total cost of revenue | 132 | 92 | 97 | 70 | 95 | 109 | 118 | 128 | 161 | 146 | 130 | 141 | 153 |
Gross margin | 791 | 834 | 813 | 890 | 876 | 917 | 963 | 1,044 | 1,081 | 1,015 | 1,151 | 1,112 | 1,147 |
Research and development | 105 | 140 | 169 | 183 | 201 | 220 | 233 | 237 | 238 | 239 | 254 | 261 | 272 |
Sales and marketing | 130 | 182 | 231 | 253 | 279 | 295 | 297 | 310 | 344 | 336 | 333 | 359 | 354 |
General and administrative | 119 | 149 | 162 | 178 | 182 | 169 | 172 | 198 | 205 | 220 | 224 | 275 | 258 |
Gain on sale of assets | - | - | - | - | - | - | - | - | - | - | 14 | - | - |
Restructuring charges | 7 | 1 | 6 | 2 | -0 | 1 | 13 | -0 | 37 | 2 | 10 | 11 | 47 |
Total operating expenses | 362 | 472 | 568 | 616 | 663 | 685 | 715 | 744 | 824 | 797 | 807 | 906 | 931 |
Operating income | 429 | 362 | 245 | 274 | 213 | 232 | 249 | 300 | 257 | 219 | 344 | 207 | 216 |
Interest income | 7 | 6 | 4 | 3 | 5 | 6 | 10 | 19 | 25 | 13 | 3 | 7 | - |
Interest income/(expense), net | - | - | - | - | - | - | - | - | - | - | - | - | 28 |
Interest expense | 1 | 0 | 1 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Other income/(expense), net | 1 | 1 | 2 | -1 | 28 | -1 | -1 | -6 | 0 | 8 | 7 | 3 | 6 |
Total other income | - | - | - | 2 | 33 | 4 | 8 | 13 | 25 | 21 | 10 | 9 | 34 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 437 | 369 | 251 | 276 | 246 | 236 | 257 | 313 | 282 | 240 | 355 | 215 | 250 |
Provision for income taxes | 154 | 104 | 60 | 67 | 63 | 50 | 54 | 190 | 27 | 8 | 37 | 31 | 48 |
Net income including controlling interest | 283 | 265 | 190 | 209 | 183 | 186 | 202 | 123 | 256 | 232 | 318 | 184 | 202 |
Less: net (income) attributable to controlling interest | -1 | 1 | 1 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 8 | -0 | - |
Net income attributable to Dolby Laboratories, Inc. | 283 | 265 | 190 | 209 | 183 | 186 | 202 | 123 | 256 | 232 | 318 | 184 | 202 |
Basic (usd per share) | 2.5 | 2.47 | 1.86 | 2.02 | 1.77 | 1.85 | 1.98 | 1.18 | 2.51 | 2.3 | 3.07 | 1.84 | 2.1 |
Diluted (usd per share) | 2.46 | 2.46 | 1.84 | 1.99 | 1.75 | 1.81 | 1.95 | 1.14 | 2.44 | 2.25 | 2.97 | 1.81 | 2.05 |
Cash dividend declared per common share | - | - | - | - | 0.42 | 0.5 | 0.58 | 0.67 | 0.79 | 0.88 | 0.91 | 1.02 | 1.11 |
Included in net income attributable to controlling interest | - | 3 | 4 | 5 | 4 | 1 | 1 | 1 | 1 | 0 | - | - | - |
Cash dividend paid per common share | - | - | - | - | 0.4 | 0.48 | 0.56 | 0.64 | 0.76 | 0.88 | 0.88 | 1 | 1.08 |
Cash dividend declared per common share | - | - | - | - | 0.42 | 0.5 | 0.58 | 0.67 | 0.79 | 0.88 | 0.91 | 1.02 | 1.11 |
Cash dividend paid per common share | - | - | - | - | 0.4 | 0.48 | 0.56 | 0.64 | 0.76 | 0.88 | 0.88 | 1 | 1.08 |